# Phase 7 Screen 2 Review Validation Matrix

## 1. Purpose

This document defines the consolidated Phase 7AP-7AT Screen 2 diagnostic review workflow validation matrix.

The matrix certifies that the Screen 2 review workflow is governed, preview-only at the UI layer, and isolated from deterministic runtime truth.

## 2. Scope

The scope covers 7AP boundary documentation, 7AQ diagnostic review object models, 7AQ.1 evidence availability review metadata, 7AR governance bridge route/intents, 7AS disabled review panel UI, import isolation, runtime safety, and documentation completeness.

## 3. Non-Goals

This validation matrix does not add new Screen 2 UI behavior, active approval controls, form POST, fetch/XMLHttpRequest, API calls, backend execution, governed write path invocation, persistence, governance execution, candidate creation, diagnostic truth mutation, Phase 4I mutation, parser/scoring/recommendation behavior changes, Phase 8 sizing/TCO, or generated dashboard writes.

## 4. Validation Categories

Required validation categories are review boundary, diagnostic review model, governance bridge, review panel, diagnostic exploration regression, import isolation, runtime safety, documentation, optional Phase 7 regression, and optional Phase 6 regression.

## 5. 7AP Boundary Validation

7AP validation proves the Screen 2 review workflow boundary exists and that review workflow is not runtime mutation.

It confirms future review actions require actor identity, governed write path, and audit trail while preserving deterministic diagnostic truth.

## 6. 7AQ Review Model Validation

7AQ validation proves local diagnostic review records, evidence review records, diagnostic approval decisions, and diagnostic review requests exist as local object models only.

No review records are persisted.

## 7. 7AQ.1 Evidence Availability Review Validation

7AQ.1 validation proves evidence availability and missing metric review metadata classify missing, unavailable, unsupported, not extracted, unreliable, and unknown evidence states.

Evidence availability review remains classification/review metadata only and does not alter diagnosis, scoring, confidence, or recommendations.

## 8. 7AR Governance Bridge Validation

7AR validation proves Screen 2 review records can map to governance route previews and candidate request intents.

Candidate intents are not candidates. No candidate is created automatically.

## 9. 7AS Review Panel Validation

7AS validation proves the Screen 2 Diagnostic Review / Approval Panel exists and all controls are disabled/preview-only.

The review panel is preview-only. No review action executes.

## 10. Diagnostic Exploration Regression

Diagnostic exploration regression validates that existing Screen 2 read-only diagnostic exploration remains intact.

The 7AS panel must not convert Screen 2 exploration into an active approval workflow.

## 11. Import Isolation Validation

Import isolation validation asserts `scripts/run_analysis.py` and parser/scoring/decision/recommendation paths do not import `screen2_review_boundary`, `screen2_diagnostic_review`, or `screen2_governance_bridge`.

## 12. Runtime Safety Validation

Runtime safety validation asserts no write is performed, no governance action is executed, no candidate is created, no diagnostic truth changes, no severity/confidence/score changes, no parser output changes, no recommendation truth changes, and no Phase 4I mutation occurs.

No active mutation functions may exist for review persistence, governance execution, candidate creation, diagnostic truth mutation, severity/confidence/score updates, parser output updates, recommendation updates, Phase 4I mutation, auto apply, or autonomous apply.

## 13. Phase 4I Boundary Validation

Phase 4I boundary validation asserts the review workflow does not mutate Phase 4I payloads, output contracts, deterministic diagnostic truth, scoring truth, parser truth, or recommendation truth.

## 14. Documentation Validation

Documentation validation asserts required 7AP-7AT architecture docs exist and contain boundary language for governed review, preview-only UI, local object models, candidate intents, deterministic runtime authority, and Phase 8 exclusion.

## 15. Phase 7 Regression

Phase 7 regression may be run when broader block confidence is needed.

It is optional for the Screen 2 review readiness script unless `--include-phase7` is provided.

## 16. Phase 6 Regression

Phase 6 regression may be run when memory/governance compatibility needs broader confirmation.

It is optional for the Screen 2 review readiness script unless `--include-phase6` is provided.

## 17. Acceptance Criteria

The Screen 2 review validation matrix is accepted when `python3 scripts/run_phase7_screen2_review_validation.py` passes, the review workflow is not runtime mutation, review panel is preview-only, no review records are persisted, no candidate is created automatically, no diagnostic truth changes, no severity/confidence/score changes, no parser output changes, no recommendation truth changes, no Phase 4I mutation occurs, deterministic runtime remains authoritative, and Phase 8 sizing/TCO is not implemented.
